ArticleLiver cancer2021

Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Claudia Campani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.